JNJ

SEC source: 0000200406-26-000008 · wk-form4_1770684007.xml · nonDerivative · entry 1

Wengel Kathryn E · CIK 0001745955 · EVP, Chief TO and Risk Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 133,225.8735

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Reflects the auto-exercise of options immediately prior to their expiration.

SEC source: 0001998491-26-000002 · wk-form4_1770777998.xml · derivative · entry 5

Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,571 shares

Expires 2026-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.expiration_date: Reflects the auto-exercise of options immediately prior to their expiration.

SEC source: 0001998491-26-000002 · wk-form4_1770777998.xml · nonDerivative · entry 2

Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,125

F2 · shares: Shares withheld for payment of the exercise price and taxes in connection with the exercise of the options reported on this Form 4.

SEC source: 0001998491-26-000002 · wk-form4_1770777998.xml · nonDerivative · entry 1

Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,460

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Reflects the auto-exercise of options immediately prior to their expiration.

SEC source: 0001950802-26-000002 · wk-form4_1770418007.xml · derivative · entry 3

Forminard Elizabeth · CIK 0001950802 · EVP, Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,921 shares

Expires 2028-02-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Vested and exercisable on the third anniversary of the date of the grant.

SEC source: 0001950802-26-000002 · wk-form4_1770418007.xml · nonDerivative · entry 2

Forminard Elizabeth · CIK 0001950802 · EVP, Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,548

F1 · price: This transaction was executed in multiple trades at prices ranging from $237.89 to $237.935. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001950802-26-000002 · wk-form4_1770418007.xml · nonDerivative · entry 1

Forminard Elizabeth · CIK 0001950802 · EVP, Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,774

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000200406-26-000004 · wk-form4_1769641662.xml · nonDerivative · entry 2

Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Indirect · By spouse

Disclosed balance after: 30,852

F2 · price: This transaction was executed in multiple trades at prices ranging from $221.38 to $221.64. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0000200406-26-000004 · wk-form4_1769641662.xml · nonDerivative · entry 1

Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Indirect · By spouse

Disclosed balance after: 79,634

F1 · price: This transaction was executed in multiple trades at prices ranging from $220.39 to $221.376. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0000200406-25-000213 · wk-form4_1765490317.xml · derivative · entry 1

Pinto Daniel E · CIK 0001555174 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 331.233

Underlying: Common Stock · 154.611 shares

Expires not disclosed

F1 · derivative.exercise_price: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.exercise_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.expiration_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

SEC source: 0000200406-25-000215 · wk-form4_1765490380.xml · derivative · entry 1

HEWSON MARILLYN A · CIK 0001217496 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,153.1187

Underlying: Common Stock · 247.378 shares

Expires not disclosed

F1 · derivative.exercise_price: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.exercise_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.expiration_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

SEC source: 0000200406-25-000217 · wk-form4_1765490532.xml · derivative · entry 1

Woods Eugene A. · CIK 0001762647 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,058.0682

Underlying: Common Stock · 185.533 shares

Expires not disclosed

F1 · derivative.exercise_price: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.exercise_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.expiration_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

SEC source: 0000200406-25-000211 · wk-form4_1764623736.xml · nonDerivative · entry 1

MORIKIS JOHN G · CIK 0001203523 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,848.51

SEC source: 0000200406-25-000204 · wk-form4_1761002033.xml · derivative · entry 3

REED JOHN C · CIK 0001181561 · EVP, Innovative Medicine, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,442

Underlying: Common Stock · 21,721 shares

Expires 2034-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0000200406-25-000204 · wk-form4_1761002033.xml · nonDerivative · entry 2

REED JOHN C · CIK 0001181561 · EVP, Innovative Medicine, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,658

F1 · price: This transaction was executed in multiple trades at prices ranging from $192.69 to $192.87. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0000200406-25-000204 · wk-form4_1761002033.xml · nonDerivative · entry 1

REED JOHN C · CIK 0001181561 · EVP, Innovative Medicine, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,379

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000200406-25-000192 · wk-form4_1757627206.xml · derivative · entry 1

Woods Eugene A. · CIK 0001762647 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,841.3962

Underlying: Common Stock · 210.591 shares

Expires not disclosed

F1 · derivative.exercise_price: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.exercise_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.expiration_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

SEC source: 0000200406-25-000194 · wk-form4_1757627315.xml · derivative · entry 1

Pinto Daniel E · CIK 0001555174 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 175.493

Underlying: Common Stock · 175.493 shares

Expires not disclosed

F1 · derivative.exercise_price: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.exercise_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.expiration_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

SEC source: 0000200406-25-000196 · wk-form4_1757627547.xml · derivative · entry 1

HEWSON MARILLYN A · CIK 0001217496 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,816.8727

Underlying: Common Stock · 280.788 shares

Expires not disclosed

F1 · derivative.exercise_price: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.exercise_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.expiration_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

SEC source: 0000200406-25-000186 · wk-form4_1757109644.xml · derivative · entry 3

Taubert Jennifer L · CIK 0001745938 · EVP, WWC. Innovative Medicine

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 56,471 shares

Expires 2026-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Vested and exercisable one day after the third anniversary of the date of the grant.

SEC source: 0000200406-25-000186 · wk-form4_1757109644.xml · nonDerivative · entry 2

Taubert Jennifer L · CIK 0001745938 · EVP, WWC. Innovative Medicine

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 178,013.001

F1 · price: This transaction was executed in multiple trades at prices ranging from $177.715 to $177.89. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0000200406-25-000186 · wk-form4_1757109644.xml · nonDerivative · entry 1

Taubert Jennifer L · CIK 0001745938 · EVP, WWC. Innovative Medicine

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 234,484.001

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000200406-25-000184 · wk-form4_1756934034.xml · derivative · entry 3

Forminard Elizabeth · CIK 0001950802 · Executive VP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,521 shares

Expires 2027-02-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Vested and exercisable on the third anniversary of the date of the grant.

SEC source: 0000200406-25-000184 · wk-form4_1756934034.xml · nonDerivative · entry 2

Forminard Elizabeth · CIK 0001950802 · Executive VP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,853

SEC source: 0000200406-25-000184 · wk-form4_1756934034.xml · nonDerivative · entry 1

Forminard Elizabeth · CIK 0001950802 · Executive VP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,423

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000200406-25-000182 · wk-form4_1756163533.xml · derivative · entry 5

Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 125,824 shares

Expires 2026-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Vested and exercisable one day after the third anniversary of the date of the grant.

SEC source: 0000200406-25-000182 · wk-form4_1756163533.xml · nonDerivative · entry 2

Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 275,967

F1 · price: This transaction was executed in multiple trades at prices ranging from $178.985 to $179.37. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0000200406-25-000182 · wk-form4_1756163533.xml · nonDerivative · entry 1

Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 401,791

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000200406-25-000180 · wk-form4_1755555550.xml · derivative · entry 5

Wolk Joseph J · CIK 0001744564 · Exec VP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 16,820 shares

Expires 2026-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Vested and exercisable one day after the third anniversary of the date of the grant.

SEC source: 0000200406-25-000180 · wk-form4_1755555550.xml · nonDerivative · entry 2

Wolk Joseph J · CIK 0001744564 · Exec VP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,000

F1 · price: This transaction was executed in multiple trades at prices ranging from $176.87 to $177.015. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0000200406-25-000180 · wk-form4_1755555550.xml · nonDerivative · entry 1

Wolk Joseph J · CIK 0001744564 · Exec VP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,820

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000200406-25-000172 · wk-form4_1752869553.xml · nonDerivative · entry 1

REED JOHN C · CIK 0001181561 · EVP, Innovative Medicine, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,658

F1 · price: This transaction was executed in multiple trades at prices ranging from $163.52 to $163.61. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0000200406-25-000154 · wk-form4_1749760229.xml · derivative · entry 1

Woods Eugene A. · CIK 0001762647 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,597.2422

Underlying: Common Stock · 231.318 shares

Expires not disclosed

F1 · derivative.exercise_price: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.exercise_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.expiration_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

SEC source: 0000200406-25-000156 · wk-form4_1749760336.xml · derivative · entry 1

HEWSON MARILLYN A · CIK 0001217496 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,437.9807

Underlying: Common Stock · 322.103 shares

Expires not disclosed

F1 · derivative.exercise_price: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.exercise_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.expiration_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

SEC source: 0000200406-25-000143 · wk-form4_1746479407.xml · derivative · entry 3

REED JOHN C · CIK 0001181561 · EVP, Innovative Medicine, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,255

Underlying: Common Stock · 25,255 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on May 1, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting.

F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on May 1, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting.

F1 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on May 1, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting.

SEC source: 0000200406-25-000143 · wk-form4_1746479407.xml · nonDerivative · entry 2

REED JOHN C · CIK 0001181561 · EVP, Innovative Medicine, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,795

F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs.

SEC source: 0000200406-25-000143 · wk-form4_1746479407.xml · nonDerivative · entry 1

REED JOHN C · CIK 0001181561 · EVP, Innovative Medicine, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,797

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on May 1, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting.

SEC source: 0000200406-25-000122 · wk-form4_1745876302.xml · derivative · entry 1

Doudna Jennifer A · CIK 0001739090 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,656.1384

Underlying: Common Stock · 1,316 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

SEC source: 0000200406-25-000123 · wk-form4_1745876377.xml · derivative · entry 1

Beckerle Mary C · CIK 0001520181 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,395.3983

Underlying: Common Stock · 1,316 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

SEC source: 0000200406-25-000125 · wk-form4_1745876478.xml · derivative · entry 1

HEWSON MARILLYN A · CIK 0001217496 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,006.9497

Underlying: Common Stock · 1,316 shares

Expires not disclosed

F1 · derivative.exercise_price: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.exercise_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.expiration_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

SEC source: 0000200406-25-000127 · wk-form4_1745876716.xml · derivative · entry 1

Johnson Paula A · CIK 0001341161 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,265.9823

Underlying: Common Stock · 1,316 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

SEC source: 0000200406-25-000129 · wk-form4_1745876902.xml · derivative · entry 1

Joly Hubert · CIK 0001467638 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,986.907

Underlying: Common Stock · 1,316 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

SEC source: 0000200406-25-000131 · wk-form4_1745877052.xml · derivative · entry 1

McClellan Mark B. · CIK 0001567006 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,755.232

Underlying: Common Stock · 1,316 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

SEC source: 0000200406-25-000133 · wk-form4_1745877141.xml · derivative · entry 1

WEINBERGER MARK A · CIK 0001785997 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,737.364

Underlying: Common Stock · 1,316 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

SEC source: 0000200406-25-000135 · wk-form4_1745877247.xml · derivative · entry 1

West Nadja · CIK 0001787802 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,572.6091

Underlying: Common Stock · 1,316 shares

Expires not disclosed

F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

SEC source: 0000200406-25-000138 · wk-form4_1745877468.xml · derivative · entry 1

Woods Eugene A. · CIK 0001762647 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,329.6642

Underlying: Common Stock · 1,316 shares

Expires not disclosed

F1 · derivative.exercise_price: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.exercise_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.expiration_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

SEC source: 0000200406-25-000103 · wk-form4_1742429234.xml · nonDerivative · entry 2

Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Indirect · By spouse

Disclosed balance after: 130,852

F1 · shares: This transaction is the Reporting Person's gift of 130,852 shares of the Issuer's common stock to his spouse.

SEC source: 0000200406-25-000103 · wk-form4_1742429234.xml · nonDerivative · entry 1

Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 275,967

F1 · shares: This transaction is the Reporting Person's gift of 130,852 shares of the Issuer's common stock to his spouse.

SEC source: 0000200406-25-000093 · wk-form4_1741297124.xml · derivative · entry 1

Woods Eugene A. · CIK 0001762647 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,013.6642

Underlying: Common Stock · 188.14 shares

Expires not disclosed

F1 · derivative.exercise_price: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.exercise_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.expiration_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

SEC source: 0000200406-25-000095 · wk-form4_1741297319.xml · derivative · entry 1

HEWSON MARILLYN A · CIK 0001217496 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,690.9497

Underlying: Common Stock · 225.768 shares

Expires not disclosed

F1 · derivative.exercise_price: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.exercise_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F1 · derivative.expiration_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.